Diagnosis and personalised treatment options for metastatic melanoma (Part 1)

2

cme-Credits

Authors/Experts

OA Dr. Ioannis Metaxas
OA Dr. Felix Kiecker
Dr. Katharina C. Kähler
Dr. Georg Richtig

Learning Targets

  • Diagnosis of metastatic melanoma
  • Sequence of BRAF inhibition and immunotherapy for metastatic melanoma
  • Prognosis of metastatic melanoma in the current era
  • Appropriate therapy and aftercare of malignant melanoma
  • Targeted therapy of malignant melanoma
  • Side effect management with BRAF and MEK inhibitors
  • Immunotherapy for malignant melanoma
  • Clarification with melanoma patients

Lecture Board

Ao.Univ.-Prof.in Dr.in med. Van Anh Nguyen
Dr. Christian Posch

Accreditation Information

The e-learning activity “Diagnosis and personalised treatment options for metastatic melanoma (Part 1)” is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The e-learning activity is awarded with 2 European CME credits (ECMEC’s).

Info für ÄrztInnen aus der Schweiz:
Die Anrechnung der CME-Credits sind bei der jeweiligen Fachgesellschaft zu beantragen.
Sie können die Teilnahmebestätigung in ihrem eigenen elektronischen Fortbildungsnachweis erfassen und archivieren.

course type image
valid until 24.05.2019
0%